Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis

Introduction: We urgently need novel treatments for multidrug-resistant tuberculosis (MDR-TB). Autologous mesenchymal stromal cell (MSC) infusion is one such possibility due to its potential to repair damaged lung tissue and boost immune responses. We aimed to assess the effectiveness of MSC to impr...

Full description

Bibliographic Details
Main Authors: Aliaksandr Skrahin, Helen E. Jenkins, Henadz Hurevich, Varvara Solodovnikova, Yanina Isaikina, Dzmitri Klimuk, Zoya Rohava, Alena Skrahina
Format: Article
Language:English
Published: Elsevier 2016-08-01
Series:Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S2405579416300018